As part of our series focussing on available medicines in Australia, we have added a product review of the use of deucravacitinib for adult plaque psoriasis.
This publication discusses the evidence supporting the use of deucravacitinib in the management of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. It also provides commentary from Clinical Professor Saxon Smith, a consultant dermatologist in private practice in Gosford and St Leonards.
Please login below to download this issue (PDF)